drugset / Trial / NCT00375557

Safety and Efficacy of Divalproex and Quetiapine in Elderly Alzheimer's Dementia Patients

NCT00375557

RandomizedParallel-groupOpen-labelTreatment

Summary

The primary aim is to determine whether Divalproex ER or one of the atypical antipsychotics is more effective improving dementia related behavioral symptoms in patients with dementia, and evaluate the impact of such improvements on other clinical domains, such as quality of life, functional status.

Timeline

Start
2006-10
Primary completion
Completion
2007-09

Drugs

EvaluationDrugModalityDoseRoute
Comparator Quetiapine Small molecule 25 mg
Comparator Valproate Small molecule 250 mg

Indications